ArticleFrontiers in immunology2019

NKT-Like (CD3+CD56+) Cells in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors.

Jani-Sofia Almeida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.